Research in the field of hormones like testosterone, prolactin and IGF-1 as individual biomarkers and putative predictors of clinical outcomes (e.g., hypertension, depression, inflammation) has been especially successful [61-66]. This evidence concerns the gene PRL and depressive symptom measurement.